Royal Bank of Canada’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Royal Bank of Canada’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-148	Closed	–	–	8047
2022 Q3	$0	Buy	+148	New	+$311	﹤0.01%	8126
2022 Q2	–	Sell	-978	Closed	-$6K	–	8001
2022 Q1	$6K	Sell	978 -2,605	-73%	-$16.4K	﹤0.01%	7226
2021 Q4	$40K	Buy	3,583 +2,053	+134%	+$28.5K	﹤0.01%	6504
2021 Q3	$25K	Buy	1,530 +455	+42%	+$8.14K	﹤0.01%	6592
2021 Q2	$20K	Buy	1,075 +347	+48%	+$6.67K	﹤0.01%	6576
2021 Q1	$11K	Sell	728 -642	-47%	-$14K	﹤0.01%	6789
2020 Q4	$44K	Buy	+1,370	New	+$18.1K	﹤0.01%	5721

Other funds holding CDAK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Royal Bank of Canada's CDAK Position: Q4 2022 in Review

Royal Bank of Canada sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q4 2022, closing a stake of 148 shares.

Royal Bank of Canada first reported a position in CDAK in Q4 2020 and held it in 7 quarters. The position peaked at $44K in Q4 2020. 40 funds tracked by Wall St. Rank hold CDAK as of Q4 2022.

Royal Bank of Canada reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Royal Bank of Canada sold 148 Codiak BioSciences, Inc. Common Stock shares in Q4 2022.
Royal Bank of Canada first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Royal Bank of Canada's Codiak BioSciences, Inc. Common Stock position peaked at $44K in Q4 2020.
40 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q4 2022.

Based on Royal Bank of Canada's 13F filing for Q4 2022, filed 14 Feb 2023.